This research aims to evaluate the clinical management and outcomes of patients with different histological subtypes of adrenal cortical carcinoma.
Analyzed data from the ENSAT cohort specifically for adrenal cortical carcinoma patients.
Compared outcomes among various histological subtypes including oncocytic ACC.
Adjusted outcomes based on cancer stage to evaluate survival rates.
Oncocytic ACC demonstrated better stage-adjusted outcomes compared to other subtypes.
Survival rates varied significantly among different histological subtypes of adrenal cortical carcinoma.
Abstract
Stage-adjusted outcome in oncocytic ACC is better than in other subtypes.
Demander à l'IA
Like
Bookmark
Share
View Full Paper
Demander à l'IA
Like
Bookmark
Share
View Full Paper
Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes—an ENSAT cohort study | Synapse